MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$2,852M
Net Income
$258M
Net Profit Margin
9.05%
EPS
$0.68
Unit: Million (M) dollars
Revenue Breakdown
Product
Product And Service Other
Revenue Breakdown
Bausch Lomb
Salix Segment
International Rx
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenues
2,852
2,524
2,796
2,681
Cost of goods sold (excluding amortization and impairments of intangible assets) and cost of other revenues-Product
753
721
783
735
Cost of goods sold (excluding amortization and impairments of intangible assets) and cost of other revenues-Product And Service Other
19
17
15
15
Selling, general and administrative
907
861
882
795
Research and development
173
163
161
166
Amortization of intangible assets
225
241
236
253
Goodwill impairments
0
1,426
145
-
Asset impairments
-
-
7
1
Restructuring, integration and separation costs
9
13
28
17
Other expense (income), net
-26
-32
-65
-80
Total expenses
2,112
3,474
2,322
2,062
Operating income (loss)
740
-950
474
619
Interest income
11
10
9
15
Interest expense
396
402
397
412
Loss (gain) on extinguishment of debt
0
-1
-19
3
Foreign exchange and other
-7
-11
-11
-7
Income (loss) before income taxes
348
-1,354
56
218
Provision for income taxes
88
77
159
37
Net income (gain)
260
-1,431
-103
181
Net (income) gain attributable to noncontrolling interest
2
-8
9
2
Net income (gain) attributable to bausch health companies inc
258
-1,423
-112
179
Basic EPS
0.69
-3.82
-0.301
0.48
Diluted EPS
0.68
-3.82
-0.293
0.48
Basic Average Shares
375,000,000
372,800,000
371,800,000
371,300,000
Diluted Average Shares
378,100,000
372,800,000
381,800,000
375,500,000
Page 1
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
Product
$2,825M
(12.82%↑ Y/Y)
Product And Service
Other
$27M
(3.85%↑ Y/Y)
Revenues
$2,852M
(12.73%↑ Y/Y)
Operating income (loss)
$740M
(66.67%↑ Y/Y)
Interest income
$11M
(-15.38%↓ Y/Y)
Total expenses
$2,112M
(1.25%↑ Y/Y)
Income (loss) before
income taxes
$348M
(148.57%↑ Y/Y)
Interest expense
$396M
(-14.84%↓ Y/Y)
Foreign exchange and
other
-$7M
(76.67%↑ Y/Y)
Selling, general and
administrative
$907M
(1.45%↑ Y/Y)
Cost of goods sold
(excluding amortization...
$753M
(0.67%↑ Y/Y)
Amortization of intangible
assets
$225M
(-12.11%↓ Y/Y)
Research and development
$173M
(8.81%↑ Y/Y)
Other expense
(income), net
-$26M
(-244.44%↓ Y/Y)
Cost of goods sold
(excluding amortization...
$19M
(18.75%↑ Y/Y)
Restructuring, integration and
separation costs
$9M
(-70.97%↓ Y/Y)
Net income (gain)
$260M
(103.13%↑ Y/Y)
Provision for income taxes
$88M
(633.33%↑ Y/Y)
Net income (gain)
attributable to bausch health...
$258M
(74.32%↑ Y/Y)
Net (income) gain
attributable to...
$2M
(110.00%↑ Y/Y)
Buy us a coffee
logo-319x31-bausch-health-svg
Bausch Health Companies Inc. (BHC)
logo-319x31-bausch-health-svg
Bausch Health Companies Inc. (BHC)
🚨
Price Alert:
The stock price jumped by 32.24% after the earning call.
Show more